Q5128 Inj, cimerli, 0.1 mg

Injection, ranibizumab-eqrn (cimerli), biosimilar, 0.1 mg

• Medicare coverage: Carrier judgment
• Status: active (July 2026 file)
• MUE: max 10 units per day (practitioner), rationale: Prescribing Information